Home › Funds › Ninepoint Partners LP › GH
Ninepoint Partners LP position in GH
GUARDANT HEALTH INC · Health Care
Ninepoint Partners LP reported holding 22,919 shares of GH (GUARDANT HEALTH INC) in its Q3 2026 13F filing — a position valued at US$4.1M, representing 0.37% of its reported portfolio and ranking #45 among its reported holdings. Ninepoint Partners LP has disclosed GH holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Ninepoint Partners LP's GH position evolved
Ninepoint Partners LP first disclosed a stake in GH in Q1 2026 at 12,994 shares (US$1.2M). The position peaked in Q3 2026 at 22,919 shares, worth US$4.1M. Across 3 filings, Ninepoint Partners LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 22,919 shares valued at US$4.1M — an increase of 3,901 shares quarter over quarter.. Notable position changes include a 46% increase in Q2 2026 (shares rose 19% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 12.99K | $1.20M | New |
| Q2 2026 | 19.02K | $2.85M | Add |
| Q3 2026 | 22.92K | $4.09M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GH and 13F data
GH (GUARDANT HEALTH INC) is a Health Care company. 60 other funds we track also report a position in GH — the largest reported positions include Deep Track Capital, LP (US$500.4M), FEDERATED HERMES, INC. (US$445.6M), EVENTIDE ASSET MANAGEMENT, LLC (US$331.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GH
- Deep Track Capital, LP 2.81M sh · $500.42M · Q3 2026
- FEDERATED HERMES, INC. 2.50M sh · $445.59M · Q3 2026
- EVENTIDE ASSET MANAGEMENT, LLC 1.86M sh · $331.73M · Q3 2026
- FULLER & THALER ASSET MANAGEMENT, INC. 1.70M sh · $303.01M · Q3 2026
- RTW INVESTMENTS, LP 1.48M sh · $264.16M · Q3 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 1.45M sh · $257.98M · Q3 2026
- Hood River Capital Management LLC 1.41M sh · $252.34M · Q3 2026
- TWO SIGMA ADVISERS, LP 2.38M sh · $243.33M · Q4 2025
- WESTFIELD CAPITAL MANAGEMENT CO LP 1.34M sh · $239.23M · Q3 2026
- Qube Research & Technologies Ltd 1.31M sh · $232.95M · Q3 2026
- WOLVERINE ASSET MANAGEMENT LLC 72.78M sh · $213.01M · Q3 2026
- AGF MANAGEMENT LTD 1.13M sh · $201.82M · Q3 2026
More on Ninepoint Partners LP
FAQ
How long has Ninepoint Partners LP held GH?
Ninepoint Partners LP has disclosed GH holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Ninepoint Partners LP's current position in GH?
As of Q3 2026, Ninepoint Partners LP holds 22.92K shares of GH (GUARDANT HEALTH INC), valued at $4.09M, representing 0.37% of its reported portfolio and ranking #45.
Has Ninepoint Partners LP been buying or selling GH?
In the latest 13F filing (Q3 2026), Ninepoint Partners LP increased its position in GH. The position peaked in Q3 2026 at 22.92K shares.
Which other funds hold GH?
Other major institutional holders of GH include Deep Track Capital, LP, FEDERATED HERMES, INC., EVENTIDE ASSET MANAGEMENT, LLC, among 60 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.